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Organotypic specificity of key RET
adaptor-docking sites in the pathogenesis
of neurocristopathies and renal
malformations in mice
Sanjay Jain,1,2,3 Amanda Knoten,1 Masato Hoshi,1 Hongtao Wang,4 Bhupinder Vohra,5
Robert O. Heuckeroth,3,4,6 and Jeffrey Milbrandt1,2,3,5
1Department

of Internal Medicine (Renal Division), 2Department of Pathology, 3HOPE Center for Neurological Disorders, 4Department of Pediatrics,
of Genetics, and 6Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri.

5Department

The receptor tyrosine kinase ret protooncogene (RET) is implicated in the pathogenesis of several diseases and
in several developmental defects, particularly those in neural crest–derived structures and the genitourinary
system. In order to further elucidate RET-mediated mechanisms that contribute to these diseases and decipher
the basis for specificity in the pleiotropic effects of RET, we characterized development of the enteric and autonomic nervous systems in mice expressing RET9 or RET51 isoforms harboring mutations in tyrosine residues
that act as docking sites for the adaptors Plcγ, Src, Shc, and Grb2. Using this approach, we found that development of the genitourinary system and the enteric and autonomic nervous systems is dependent on distinct
RET-stimulated signaling pathways. Thus, mutation of RET51 at Y1062, a docking site for multiple adaptor
proteins including Shc, caused distal colon aganglionosis reminiscent of Hirschsprung disease (HSCR). On
the other hand, this mutation in RET9, which encodes an isoform that lacks the Grb2 docking site present in
RET51, produced severe abnormalities in multiple organs. Mutations that abrogate RET-Plcγ binding, previously shown to produce features reminiscent of congenital anomalies of kidneys or urinary tract (CAKUT)
syndrome, produced only minor abnormalities in the nervous system. Abrogating RET51-Src binding produced no major defects in these systems. These studies provide insight into the basis of organotypic specificity
and redundancy in RET signaling within these unique systems and in diseases such as HSCR and CAKUT.
Introduction
Aberrant signaling by receptor tyrosine kinases (RTKs) leads to
congenital malformations, cancer, and stem cell renewal defects.
Upon activation, RTKs typically interact with intracellular adaptor
proteins (PLCγ, SRC, SHC, GRB2) via docking phosphotyrosines
to activate intracellular signaling cascades, such as PKC, AKT, and
MAPK, that regulate cellular proliferation, survival, migration,
and self renewal (1). While studies of mutant mice have elucidated
physiological roles of several RTKs, little is known about the relative contributions of individual signaling cascades in producing
the diverse phenotypes that result from RTK dysfunction.
Mutations in rearranged during transfection (RET) protooncogene, a transmembrane RTK, cause multiple human diseases,
particularly those affecting neural crest–derived structures (enteric
ganglia, parasympathetic and sympathetic ganglia, thyroid C cells,
and adrenal medulla) (2). Inactivating RET mutations are a common cause of Hirschsprung disease (HSCR) (3), or distal intestinal aganglionosis, as well as renal agenesis (4). In contrast, activating RET mutations lead to human multiple endocrine neoplasia
(MEN) syndromes 2A and 2B, 2 life-threatening familial cancer
predisposition syndromes. Recently, RET mutations have been
found in patients presenting with multiple abnormalities, including HSCR, with congenital anomalies of kidneys or urinary tract
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(CAKUT), or HSCR and MEN2, or CAKUT and MEN2 (5–7). It is
unclear how RET-mediated signaling cascades lead to anomalies in
isolated or combined presentation of these anomalies.
RET signaling is activated by the formation of a receptor complex that includes a member of the glial cell line–derived neurotrophic factor (GDNF) family ligands (GFLs), which includes
GDNF, Neurturin, Artemin, and Persephin, along with a GDNF
receptor α (GFRα) coreceptor (GFRα1–4) (8). The specificity of
these interactions is dependent on the coreceptor-ligand interaction, with the RET tyrosine kinase serving as a common signaling component. A number of studies in mice have defined the
importance of Ret signaling in the development and maintenance
of the peripheral nervous system (PNS), with particular emphasis on the autonomic nervous system (ANS), enteric nervous system (ENS), and the urinary and reproductive systems (9–13). For
example, mice lacking Gdnf, its cognate coreceptor Gfrα1, or Ret
all have similar and severe deficits that include complete intestinal
aganglionosis, agenesis of sphenopalatine ganglia, migration and
neuronal projection defects in the sympathetic ganglia, and bilateral renal agenesis (10, 14–20).
RET activation results in phosphorylation of key docking tyrosines that bind to several intracellular adaptor proteins such as
SRC (at Y981), PLCγ (at Y1015), SHC, FRS2, IRS1 and -2, ENIGMA,
DOKs 4, 5 and 6 (at Y1062), and GRB2 (at Y1096) (21). Recruitment
of SRC to RET Y981 activates the MAPK pathway, while recruitment of PLCγ binding to RET Y1015 primarily activates the PKC
pathway (21). The RET Y1062 phosphotyrosine serves as a dock-
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Table 1
List of RET-mutant mice used
Homozygous mutant studied
Ret RET9/RET9
Ret RET51/RET51
Ret RET51(Y981F)/RET51(Y981F)
Ret RET51(Y1015F)/RET51(Y1015F)
Ret RET51(Y1062F)/RET51(Y1062F)
Ret RET51(Cdel)/RET51(Cdel)
Ret RET9(Y981F)/RET9(Y981F)
Ret RET9(Y1015F)/RET9(Y1015F)
Ret RET9(Y1062F)/RET9(Y1062F)
Ret RET9(51C)/RET9(51C)

Simple name used
RET9
RET51
RET51(Y981F)
RET51(Y1015F)
RET51(Y1062F)
RET51(Cdel)
RET9(Y981F)
RET9(Y1015F)
RET9(Y1062F)
RET9(51C)

Shown are the homozygous mutant mice expressing the knocked in
human RET alleles and the simplified allele names that are used in the
manuscript.

provides redundancy in both the ENS and PNS. For example, ENS
and parasympathetic ganglia showed minimal deficits in mice
expressing RET51 docking site mutants, whereas mice expressing
comparable RET9 mutations showed varying degrees of intestinal
aganglionosis and agenesis of key parasympathetic ganglia as well
as sympathetic nervous system defects. The phenotypes of these
RET mutants (singly or in combination) resemble HSCR and/or
CAKUT, including the characteristic incomplete penetrance and
variable expressivity of these syndromes. By systematically examining the role of each adaptor singly or in combination with the
absence of the Y1096 Grb2-binding site, these studies provide
valuable insights into the mechanistic basis for the variable phenotypes observed in HSCR or CAKUT.
Results
Parasympathetic, but not enteric or sympathetic, ganglia require RET51
isoform for proper development. To investigate the relative contributions of the 2 major RET isoforms, RET9 and RET51, in PNS
development, we studied mice that exclusively express 2 copies
of WT human RET9 or RET51. These knockin mice, and each of
the homozygous RET mutants studied, were generated previously
using homologous recombination of human RET cDNAs into the
endogenous Ret locus (knockout-knockin approach) (Figure 1
and Table 1) (29). All analyses performed in this study were on
homozygous mice. For PNS analyses, we selected structures that
are severely affected in Ret- or GFL-null mice, including the ENS
and the cranial parasympathetic sphenopalatine ganglia (SPG)
and superior cervical sympathetic ganglia (SCG) of the ANS (9,
10, 19). Most of the analyses were performed on newborn mice

ing site for multiple adaptors. It primarily supports SHC binding
to recruit either the GRB2-SOS complex leading to MAPK activation or GRB2-GAB1 to stimulate PI3K/AKT signaling. GRB2 also
binds directly to phospho-Y1096, where it preferentially activates
PI3K/AKT signaling (22).
There are 2 major alternative splice isoforms of RET, RET9 and
RET51, that may differentially modulate RET-activated intra
cellular signaling cascades. RET9 (1072 aa) and RET51 (1114 aa)
diverge after residue 1063 and thus are identical except for the
C-terminal cytoplasmic domain (23). RET51 carboxyl terminus
contains an additional docking tyrosine, Y1096,
for GRB2. The physiologic roles of these 2 isoforms
and the signaling pathways emanating from specific
phosphorylated tyrosine docking sites have been
studied in vitro, but information in vivo is limited.
The relative importance of the RET isoforms and
particular docking sites has differed depending on
the system investigated (24–27). For example, in mice
exclusively expressing chimeric mouse-human WT
Ret9 or Ret51, only Ret9 supported normal kidney
or ENS development (28). However, normal kidney
development is supported in mice expressing either
WT human RET9 or RET51. Only when individual
RET docking sites were mutated did the distinct
roles of these key signaling pathways and isoforms in
genitourinary development become apparent (29).
To delineate the RET signaling pathways criti- Figure 1
cal for the formation of the PNS, we characterized Schematic of the various RET-mutant mice used in this study. (A) Simplified diagram
of mutant or WT human RET cDNAs homologously recombined into exon 1 (black box)
the ENS and ANS in 10 different mutant mice in
of the mouse Ret locus using knockout-knockin approach (29). (B) Schematic of the
which key RET docking sites were mutated in both different WT RET9, RET51, and their respective mutant knocked in alleles is shown.
the RET9 and RET51 isoforms. We found that either The different domains and sizes of RET9 and RET51 are indicated. The area of diverRET9 or RET51 could support normal ENS develop- gence between the 2 RET isoforms is indicated in red or blue. Also indicated are the
ment, contrary to a previous report (28); however, key docking tyrosine (Y) residues, the major intracellular adapters that dock at these
dramatic differences were observed when individual tyrosines, and the downstream signaling cascades. Homozygous mice were generphosphotyrosine docking sites were mutated in the ated that harbor Tyr-to-Phe (Y to F) mutations for each of the indicated Tyr except
context of the RET9 vs. RET51 isoform. In general, Y1096. In the RET51(Cdel) allele, residues 1063–1072 of RET9 were replaced with
residues 1063–1072 of RET51. This results in a receptor that is essentially RET51
mice deficient in a particular adaptor site in the
with a deletion of residues 1073–1114, including Y1096. In the RET9(51C) allele,
RET51 context exhibited abnormalities that were residues 1063–1072 of RET51 were replaced with residues 1063–1072 of RET9.
less severe than those observed in mice harboring This results in a receptor that is essentially similar to RET9 with C terminus of RET51,
the same mutation in the context of RET9, indicat- including Y1096. Note Grb2 can directly bind to RET51 and also indirectly to Y1062
ing that the additional Grb2 site (Y1096) in RET51 in both RET9 and RET51.
The Journal of Clinical Investigation    http://www.jci.org    Volume 120    Number 3    March 2010

779

Downloaded on August 28, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/41619

research article

Figure 2
RET51 is sufficient to support ENS and sympathetic nervous system development and is necessary for the development of cranial parasympathetic ganglia. (A) RET9 and RET51 can both support normal ENS development. Whole-mount AChE staining (to visualize ENS formation) from WT
or the indicated RET51 and RET9 mice (at postnatal day zero, P0) show typical dense reticular,
honeycomb-like distal colon staining, indicating normal ENS colonization by both RET isoforms.
(B) Redundant roles of RET isoforms in development of sympathetic ganglia. Whole-mount TH
immunohistochemistry (brown color) shows normally located SCG and normal projections to the
eye (white arrowhead) and submandibular gland (SM, black arrowheads). (C) RET9 alone is
unable to fully support parasympathetic ganglia development. Nissl-stained sections of head from
P0 mice show normal location of SPG in WT and RET51 (arrows) mice, but a subset of RET9 mice
show unilateral SPG agenesis (dashed oval) (see E–H for orientation). (D) Reduced harderian
gland innervation in RET9 mice (1- to 2-month-old mice) was observed with anti-TuJ1 immuno
histochemistry (red fibers). While TuJ1-positive fibers surround almost all acini in WT and RET51
mice, RET9 harderian glands show reduced innervation consistent with incompletely penetrant
unilateral agenesis. (E–H) Anatomical and histological landmarks for SPG analysis. Vertical bar
in E shows approximate level of histological sections. (F) Coronal section showing SPG location
(white arrow); boxed area is shown at higher magnification in G, which also represents images
in C and Figure 7A. (H) Closer view of SPG of one side denotes approximate representation of
images in Figure 7B. Scale bars: 400 μm (A); 600 μm (B); 200 μm (C); 100 μm (D); 50 μm (inset);
F, 1 mm. br, brain; sep, septum; mu, eye muscles; np, nasopharynx; mn, maxillary nerves; oa,
orbital artery; ov, orbital vein; spa, sphenopalatine ganglion.
780

(P0), as these structures are largely
developed at birth, and many of these
mutant animals die shortly after birth
due to severe renal (29) or intestinal
abnormalities (see below).
To determine whether the intestinal
aganglionosis in Ret-null mice could
be attributed to a specific Ret isoform,
we used acetylcholinesterase (AChE)
staining to visualize the ENS in mice
expressing solely RET51 (RetRET51/RET51)
or RET9 (RetRET9/RET9). In a previous
report, Ret9 was found to be critical
for intestinal innervation (28); however, we found that either isoform
was capable of supporting ENS development. AChE-stained neurons and
a normal myenteric neuronal plexus
were detected throughout the small
and large bowel in these mutant mice
(Figure 2A; data not shown).
Previous analysis of Ret-null and
Artemin-null mice showed that Ret
signaling is important for sympathetic neuron precursor migration and
axonal projection (10, 30). In these
mutants, the SCG fails to migrate to
its proper location, resulting in accompanying abnormalities in projections
to the submandibular gland and muscles of the eye. The stellate and sympathetic chain ganglia and their axonal projections are also abnormally
developed in these mutant mice. We
next searched for isoform-specific
differences in sympathetic nervous
system development. We used tyrosine hydroxylase (TH) whole-mount
immunohistochemistry to visualize
the sympathetic nervous system in
homozygous RET9 and RET51 mice.
We found that it developed normally,
with properly located SCGs and normal innervation of its targets and
normally formed sympathetic chain
(Figure 2B and data not shown).
Finally, we investigated to determine whether RET9 and RET51 mice
were able to support parasympathetic
ganglia development. The SPG, which
innervates the harderian/lachrymal
glands, fails to develop in Ret-null mice
due to defective precursor proliferation
(9). Histological analysis of P0 head
sections using Nissl staining revealed
normally localized SPGs in RET51
mice (Figure 2C). However, a subset
of RET9 mice had unilateral agenesis
of the SPG (25%), which was accompanied by reduced harderian gland
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Figure 3
Essential role of the RET-Shc multidocking site in distal colon innervation. To determine roles of individual RET adaptor sites in ENS development, AChE whole-mount staining to visualize the ENS was performed on intestines (P0) of the indicated adaptor mutants in the context
of RET51 isoform (Y981F, Src adaptor; Y1015F, Plcγ adaptor; Y1062F, Shc adaptor; or null, KO). Neuronal plexus and ganglion formation,
depicted by typical reticular, honeycomb like staining pattern at ileocecal (IC) junction and distal colon, occurs in all adaptor mutants except for
RET51(Y1062F). The RET51(Y1062F) image shows distal colon with absent enteric ganglia and plexus, but readily visible thick extrinsic nerve
fiber bundles similar to those observed in Ret-null mice. Varying degrees of colon aganglionosis were seen in RET51(Y1062F) mice. Compared
with aganglionosis in terminal ileum (TI) of Ret-KO mice, AChE staining of the intestines in RET51(Y1062F) mice detected both a neuronal plexus
and ganglia in the TI. The schematic summarizes the extent of bowel colonization by ENS precursors in mutant mice. For RET51(Y1062F), each
pentagon represents the location of the most distal enteric ganglion cell in an individual mutant; for other mouse lines, single pentagons represent
the entire group, since none of these mice had bowel aganglionosis (refer to graph in Figure 4B for number of mice analyzed for each mutant
mouse and associated ENS abnormality). Scale bars: 600 μm (IC junction); 400 μm (distal colon).

innervation compared with WT mice as assessed by TuJ1 immuno
histochemistry (WT = 10821 ± 977, n = 3; RET9 = 2040 ± 297,
n = 3; mean innervation area pixel2 ± SEM, P < 0.001); innervation in
RET51 and WT harderian glands were similar (RET51 = 8862 ± 661,
n = 3, mean ± SEM, P = 0.1) (Figure 2D). These results indicate that
the WT forms of RET9 and RET51 have redundant roles in morphologically normal ENS and sympathetic nervous system development. However, RET9 alone is insufficient to promote proper SPG
development, suggesting that Grb2-mediated signaling through
Y1096 is important in this process.
Signaling through RET51-Y1062 is essential for distal colon innervation.
Four phosphotyrosines in the RET cytoplasmic domain serve as
major docking sites for intracellular adaptors that initiate downstream signaling cascades. We next sought to delineate which of
these RET docking sites, Y981 (site for Src interaction), Y1015
(site for Plcγ interaction), Y1062 (interacts with Shc and other
intracellular adaptors) and Y1096 (a site only present in RET51
that interacts with Grb2), play critical roles in the ENS in order to
gain new mechanistic insights into RET-mediated HSCR.
We used AChE staining to examine the ENS of mice expressing
human RET51 in which each of these docking sites was individually mutated (Y to F mutants) or, in the case of Y1096, by using a
C-terminal deletion mutant (RET51Cdel) (Figure 1 and Table 1)

that lacks this residue (25, 26, 28, 29). We observed remarkable
differences in colonic ENS structure in these mutants, which were
highly reminiscent of long (aganglionic segment proximal to the
rectosigmoid colon) and short segment (aganglionosis confined
to rectosigmoid region) HSCR. The enteric plexus and neurons in
the distal bowel were absent (i.e., aganglionosis) in mice expressing
the RET51(Y1062F) mutant (lacks Shc adaptor site), with the length
of aganglionic segment varying from the distal colon only to total
colon aganglionosis (Figure 3). Notably, these mice do not have significant renal abnormalities (29), but do not survive to adulthood
due to complications of the HSCR-like phenotype (i.e., megacolon,
ruptured bowel). Thus, abrogating RET-Shc–mediated signaling has
a severe effect on the ENS, but not on urogenital development.
Further, we found that RET51(Y1015F) mice (lack RET-stimulated
Plcγ signaling) do not have major abnormalities in the ENS in contrast, with the crucial importance of this pathway in supporting
normal urogenital development (29). The majority of these mutant
mice showed normal distal colon innervation (13/16), with only a
small subset manifesting distal colon hypoganglionosis (Figure 3
and Figure 4B). We also found normal intestinal innervation in
RET51(Cdel) mice (RET51 C-term deletion, which lack the direct
Grb2 binding site Y1096), RET9(51C), or RET51(Y981F) (lack Src
binding site) (Figure 3, Figure 4B, and data not shown). The pheno-
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Figure 4
Severe ENS defects in RET tyrosine docking mutants lacking the Grb2-binding site. (A) Whole-mount AChE staining was used to visualize the
ENS in P0 intestines in RET9 or the indicated RET9 docking tyrosine mutant mice. Regions of the bowel from the distal colon and duodenum are
shown. WT RET9 monoisoformic animals have a normal-appearing dense reticular staining pattern in the duodenum and the distal colon, while
RET9(Y981F) (Src mutants) have colon aganglionosis but normal duodenum staining. RET9(Y1015F) (Plcγ) mice have neuronal ganglia and
plexus in the colon but at reduced density (hypoganglionosis); duodenum innervation is normal. RET9(Y1062F) mice manifest complete intestinal
aganglionosis, as no neurons are present in colon or in duodenum. A compound isoformic Y1062F mutant (RET9/51[Y1062F]) has intermediate
aganglionosis compared with RET51(Y1062F) (Figure 3) and RET9(Y1062F) mice, indicating isoform dosage influences intestinal innervation.
(B) The bar graph summarizes the innervation phenotypes of all the RET9 and RET51 WT and adaptor mutants examined. Numbers in the bars
represent the number of mice with that phenotype. Scale bars: 600 μm (duodenum); 400 μm (distal colon).

types of these mutant mice indicate that in the context of RET51, the
Src adaptor site, Grb2-binding site, and the C-term tail are largely
dispensable for normal ENS (Figure 4B and Table 2) as well as renal
development (29). Furthermore, these results demonstrate that the
ENS and genitourinary (GU) systems have different thresholds to
the loss of RET-Plcγ (results in CAKUT) and RET51-Shc (results in
HSCR) mediated signaling for normal development.
Docking site mutations in RET9 cause severe ENS defects. The RET9
isoform differs from RET51 in that it lacks the C-terminal tail that
contains the Grb2 docking site (Y1096), important for activation of
the AKT/MAPK pathways. This site provides redundancy to the Src
and multidocking Shc sites for normal kidney development, as its
782

absence in several of the RET9-Tyr mutants leads to increased severity of kidney abnormalities (29). Therefore, we explored whether this
site was also important in ENS formation. AChE staining of postnatal gastrointestinal tracts from mice expressing RET9 mutations
(Y981F, Y1015F or Y1062F) revealed a spectrum of phenotypes that
were more severe than those of mice expressing the corresponding
RET51 mutations. For example, while the ENS of RET51(Y981F)
mutant mice appeared normal, RET9(Y981F) mice manifested partially penetrant distal intestinal aganglionosis (9/18) in which the
extent of aganglionosis ranged from the distal third of the colon
only to the entire colon and terminal ileum (Figure 4). Interestingly,
the RET9(Y981F) mutant mice previously showed the pattern of
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AA

Type adaptor affected
Genitourinary
Renal agenesis, unilateral
Renal agenesis/aplasia,
bilateral
Hypoplasia
Dysplasia
Hydro/megaureter,
unilateral
Hydro/megaureter,
bilateral
Supernumerary ureters
Gonadal dysgenesis
Gastrointestinal
Colon hypoganglionosis
Colon aganglionosis
Ileum + colon
aganglionosis
Total intestinal
aganglionosis
Sympathetic
SCG migration/projection
Sympathetic chain
abnormal
Parasympathetic
SPG absent, unilateral
SPG absent, bilateral

Homozygous RET
RET51
mutant		

Table 2
Comparative summary of RET isoforms/docking site mutants and associated main developmental abnormalities
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Figure 5
Grb2 and Plcγ are essential for maintaining normal enteric neuron
number. Roles of Grb2, Plcγ, and Shc adaptor proteins in regulating
enteric neuron number were examined in vitro. ENS precursors were
harvested from E14.5 rat intestines using p75NTR immunoselection and
propagated in culture for 7 days. Indicated siRNAs or control (scrambled siRNA) were delivered by lentivirus infection 1 day after plating
the cells. Tau1 immunofluorescence was used to detect neurons and
their neurites (arrows). Shc siRNA did not affect cell number compared
with control. Plcγ and Grb2 siRNA caused a severe reduction in neuron numbers. The y axis represents neurons remaining relative to the
beginning of the culture. The graph at the bottom shows quantification
results from 3 independent experiments (mean ± SD, *P < 0.05 versus
control). Scale bar: 25 μm.

incomplete penetrance and variable expressivity in CAKUT (29)
(Table 2). Thus, abrogated Src adaptor site binding in the face of
reduced Grb2-mediated signals (i.e., RET9 context) increases the
propensity to develop both HSCR and CAKUT phenotypes.
In contrast with the abnormalities in the RET9(Y981F) mutants,
RET9(Y1015F) mutants (lack Plcγ binding) have normal-appearing
small intestinal innervation and show only a partially penetrant
distal colon hypoganglionosis (15/17) (Figure 4, A and B). While of
moderate severity, these colon ENS abnormalities are significantly
worse than those observed in RET51(Y1015F) mice. We noted that
the differences in penetrance and severity of ENS deficits between
RET9-Plcγ and RET51-Plcγ mutants (Figure 4) were not observed in
the genitourinary system in which both mutants manifested severe
genitourinary defects (29) (Table 2). We also examined the ENS
of RET9(Y1062F) mice (lack binding to Shc and other adaptors).
We found that these mice have complete intestinal aganglionosis with 100% penetrance, a phenotype that is similar to Ret-null
and mouse-human-chimeric-Ret9(Y1062F) mutant mice (19, 31).
These deficits were more severe than in RET51(Y1062F) mutant
mice analyzed above in which aganglionosis is limited to the colon
and further support the idea that Grb2 signaling via the RET51specific Y1096 docking site is important for proper development
of the ENS. Finally, compound isoformic RET(Y1062F) mutant
mice (Ret RET9(Y1062F)/RET51(Y1062F)), which harbor single mutant
RET9(Y1062F) and RET51(Y1062F) alleles, had an intermediate
phenotype, with aganglionosis affecting colon and terminal ileum
that is reminiscent of long-segment HSCR (32) (Figure 4A). We
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did not observe any overt differences between males and females
for aganglionosis or hypoganglionosis phenotypes in the mutant
mice analyzed above. Taken together, these results suggest that
activation of AKT and MAPK signaling through Y1062 that serves
as a docking site for Shc and other adaptor proteins is necessary
for complete colonization of the colon.
To further determine the importance of Grb2-mediated signaling in ENS development, we isolated and cultured ENS precursors from E14.5 WT rat bowel using P75 immunoselection (see
Methods). We infected these with lentiviruses expressing siRNAs
directed against either Grb2, Shc, or Plcγ and performed analysis
using TuJ1 and Tau1 immunocytochemistry (33) (see Methods).
Grb2 knockdown resulted in a marked reduction in enteric neuron number compared with control or Shc siRNA–expressing cells,
further confirming the essential role of Grb2 in ENS development;
both Tau1 and TuJ1 immunocytochemistry revealed similar reductions in neuronal number (Figure 5 and data not shown). The fact
that Shc knockdown did not have a major effect on enteric neuron
number suggests redundancy/compensation through other adaptors and is consistent with milder ENS phenotype observed in
RET51(Y1062F) mutant mice, which harbor the additional Grb2binding site. Interestingly, Plcγ knockdown also caused a dramatic
reduction in neuronal numbers despite the minor ENS deficits
in RET(Y1015F) mice, suggesting that Plcγ activation via signals
other than RET may be important in ENS development.
Sympathetic nervous system development is relatively resistant to mutation of individual RET docking sites. Artemin-stimulated RET signaling is important for sympathetic neuron precursor migration and
subsequent axonal projection. To decipher RET-dependent pathways that govern sympathetic ganglia formation, we used wholemount TH immunohistochemistry to visualize the sympathetic
nervous system in these RET-mutant mice. We found that individual docking sites for Plcγ, Src, Shc, and Grb2 in RET51 isoform are all dispensable for sympathetic nervous system development (Figure 6, Table 2, and data not shown). When we examined
mice expressing RET9 with these mutations, we again found few
deficits in the sympathetic nervous system. These included moderate, unilateral abnormalities in SCG migration, sympathetic
chain development, and neuronal projection defects in a subset
of RET9(Y1062F) mutant mice (5/8) (Figure 6). These results are
in stark contrast to the deficits observed in the ENS and in kidney
development in these mice (Table 2), suggesting that sympathetic
nervous system development has a different threshold to aberrant
Ret-Tyr signaling than other systems or depends on a high degree
of Ret-mediated signaling redundancy.
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Figure 6
Sympathetic nervous system defects in RET
mutants lacking Shc and Grb2 binding sites.
Whole-mount TH immunohistochemistry was
performed on P0 pups to assess sympathetic nervous system development in RET9 and RET51
signaling mutants. (A–C) Normal sympathetic
nervous system develops in (A) RET9(Y981F)
(Src mutant) and (B) RET9(Y1015F) (Plcγ
mutant) mice, as demonstrated by normal SCG
location and normal innervation to submandibular
gland (SM, black arrowheads) and the eye (blue
arrowhead). (C) Ret-null mice show abnormal
caudal location of the SCG, next to the stellate
ganglion (STG) instead of the expected normal
location (dashed oval); innervations to the SM or
the eye are absent. (D–H) RET9(Y1062F) adaptor mutants (lack Shc- and Grb2-binding sites)
show a spectrum of sympathetic nervous system defects albeit milder than Ret-null animals.
These include normal SCG location and projections to eye (blue arrowhead) and submandibular
gland (black arrowhead in D), failure of SCG to
migrate normally (E and F; dashed circle depicts
expected location), mislocalization of the SCG
near the stellate ganglion (STG) in G, and fusion
of rostral sympathetic chain ganglia (black arrowhead) with the STG, resulting in a gap in the
sympathetic chain (double arrowhead) in H. (I)
Sympathetic chain (sc) ganglia in RET9(Y1062F)
mice are small (black arrows), or absent (dashed
oval) and have diminished to absent axonal outgrowths compared with WT mice (blue arrows)
in J. (K–M) Docking site mutations in the context
of RET51 do not disrupt sympathetic nervous
system development. Representative pictures
are shown for the indicated adaptor mutants in
RET51 context, highlighting normal sympathetic
ganglia development. Scale bars: 600 μm (A–H
and K–M); 400 μm (I, J).

Severe parasympathetic nervous system defects in RET9 docking tyrosine mutant mice. In all the RET-dependent organs examined (ENS,
sympathetic nervous system, kidneys), RET9 docking site mutants
(lack Grb2 binding at Y1096) manifest more severe defects than
mice expressing their RET51 counterparts. To extend this analysis
to the parasympathetic nervous system, we examined SPG development in these mutant mice. The SPG failed to develop in a large
number of RET9-Tyr mutants, and these were generally more severe
than mice expressing WT RET9 (Figure 2C and Figure 7). For
example, RET9(Y981F) (lack Src binding) and RET9(Y1015F) (no
Plcγ binding) mutants showed partially penetrant unilateral and
bilateral SPG agenesis, with accompanying reduced innervation to
the harderian gland in the postnatal period (Figure 7, A–C and E).
Importantly, RET9(Y1062F) mutants (no Shc or Grb2 binding)
have completely penetrant bilateral SPG agenesis, as observed in
Ret-null mice (Figure 7A). We counted the number of Nissl-stained
neurons in these mutant mice using serial sections of the entire
SPG and found that when the SPG is present (i.e., no agenesis), the
ganglia contained a normal number of neurons (Figure 7D). Notably, histological analysis of P0 head sections using Nissl staining
revealed normal localization of SPGs and normal neuronal numbers in all mutants in the RET51 context (Figure 7 and data not

shown). More severe SPG defects in RET9 mutants again indicate
that Grb2 signaling from RET51 C terminus is important for normal development of the parasympathetic nervous system.
Discussion
Inactivating RET mutations are the most commonly identified cause
of human HSCR and have recently been implicated in renal agenesis
(3, 7). Activating RET mutations cause MEN2A and MEN2B, familial cancer predisposition syndromes affecting the adrenal medulla,
parathyroid, and thyroid (34). Many of these mutations are in the
cytoplasmic domain of RET. The activation of major signaling proteins such as PLCγ, SRC, PI3K, and MAPK by GFL signaling depends
on key RET docking tyrosines for intracellular adaptors. One poorly
understood aspect of these disease associations is the molecular
mechanisms that underlie organ- or tissue-specific effects of RET
mutations in human disease and the role of these RET-activated
pathways in organogenesis. Through the analyses of mutant RET
allelic series, new insights into the role of RET isoforms and signaling pathways in the ENS and ANS development as well as congenital diseases caused by RET mutations have been made. In particular,
through our comparative analyses, we found remarkable specificity in the signaling systems required for each region and demon-
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Figure 7
Severe parasympathetic nervous system defects in RET9 docking tyrosine mutant mice. Cranial parasympathetic SPG and their innervation of
the harderian gland using Nissl staining (P0 pups) and TuJ1 immunohistochemistry (1- to 2-month-old mice), respectively. Refer to Figure 2,
E–H, for anatomical landmarks for SPG and key for annotations. (A and B) RET9(Y1062F) mice exhibit (n = 14) bilateral SPG agenesis, a
phenotype similar to that of Ret-null mice (dashed oval, expected normal SPG site); RET51(Y1062F) SPG were normally located (arrows in
A and B). RET9(Y981F) and RET9(Y1015F) mice showed incomplete penetrance of SPG agenesis, including normal SPG location bilaterally (arrows in A), unilateral, or bilateral SPG agenesis (SPG agenesis indicated by dashed ovals in B and summarized in E). (C) Differences
in innervations (TuJ1 staining, red fibers surrounding each acinus) of the 2 harderian glands from the same mutant mouse. Note that gland
1 of each mutant had TuJ1-positive fibers surrounding all acini, but gland 2 innervation was markedly decreased or absent, consistent with
SPG unilateral agenesis (closer view shown in the inset). (D) Summary of SPG neuronal numbers in RET mutants, in which SPG are formed.
Quantification of neuron numbers in SPG show no significant differences in mutant and WT mice except RET9(Y1062F) mice, which had SPG
agenesis. The graph depicts number of neurons in each completely sectioned SPG (mean ± SEM; numbers at the bottom denote SPG used
per genotype). (E) Spectrum of SPG abnormalities observed in RET-mutant mice. Results of SPG location from both RET51 and RET9 mutant
mice are summarized in the bar graph. Numbers in each colored bar represent the number of SPG with the corresponding defect. Scale bars:
200 μm (A); 50 μm (B); 100 μm (C); 50 μm (inset).
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Figure 8
Summary model depicting the main tissues affected by key docking tyrosines activated by GFL-RET signaling. One of the 4 GFLs binds 1 of
the 4 GFRα coreceptors and forms a multimeric complex with RET leading to receptor activation. The phosphorylated docking sites on each of
the major isoforms, RET9 and RET51, interact with the indicated adaptors and the signaling cascades. RET9 lacks the extra GRB2-binding site
(Y1096), and defects in general are more severe and affect more systems when the docking sites are mutated in RET9 context. Asterisks on the
MAPK/PI3K pathways denote partial reduction due to redundant activation through intact Y1062 or Y1096.

strated redundancy in RET-dependent signaling for organogenesis,
with some mutations affecting the ENS but not renal development,
whereas others (Plcγ signaling) have more severe effects on kidney
formation than on the ENS.
One important aspect of our study is the finding that both the
human RET isoforms, RET9 and RET51, support normal ENS
and sympathetic nervous system development in mice. Previous
in vitro studies have presented contrasting views regarding the
relative importance of these isoforms and each has been touted
as more crucial (35, 36). An additional study regarding the in vivo
roles of Ret isoforms concluded that Ret51 could not support
normal kidney or ENS development, whereas the formation of
these systems was normal in Ret9-expressing mice (28). In contrast, our studies point to redundant roles of the RET isoforms
in that we observed the development of morphologically normal
kidneys, ENS, and sympathetic nervous system, with only the
parasympathetic system demonstrating isoform-specific requirements. The reasons for these differing results are unclear and have
been discussed before (29). These include different properties of

the chimeric mouse-human Ret51 or Ret9 proteins used in the
de Graaff study (28) that contain mouse genomic region encompassing the extracellular domain versus the cDNAs of the human
isoforms used in our study (Table 2). There may also be environment or genetic strain differences that account for our different
results. Nevertheless, the observations raise the possibility that
RET isoforms could play alternative roles depending on genetic
or environmental contexts.
The availability of mice with individual mutations in each
RET isoform enabled us to systematically determine the role of
each adaptor site individually in PNS development. In general,
RET9 mutations caused more severe abnormalities than comparable mutations in the RET51 isoform (Figure 8 and Table 2). For
example, RET51(Y981F) (Src site) or RET51(Y1015F) (Plcγ site) did
not prevent colonization of the bowel by ENS precursors, whereas
these same mutations in the RET9 context resulted in hypoganglionosis (Y1015F) or aganglionosis (Y981F) of the distal bowel
in a large number of animals. Further, mutations in Y1062 also
caused more severe abnormalities in the RET9 context (complete
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intestinal aganglionosis) than in RET51 animals (only distal colon
aganglionosis). Each of these observations suggests an important
role for Grb2 signaling in ENS development, a hypothesis supported by our Grb2 knockdown experiments with ENS precursor
cells and by previous studies in vitro (35, 37, 38). Similar increases
in the severity of observed defects were found in the parasympathetic and sympathetic ganglia, consistent with an important
role for Grb2 in GFL-mediated nervous system development.
Overall, this increased severity may be due to synergistic effects
on PI3K/AKT and MAPK activity in these RET-dependent tissues
due to the lack of this additional Grb2-binding site in RET9 mice.
Biochemical characterization of PI3K/AKT and MAPK activity in
neurons from these mutant animals showed modest reductions in
RET9(Y981F) and RET9(Y1015F) mutants and complete abrogation of PI3K/AKT and MAPK activity in RET9(Y1062F) mutants
(29, 39). These results are consistent with redundancy mediated
by Grb2 interactions at Y1062 (via Shc) or direct binding at Y1096
and highlight the differences in RET51 versus RET9 signaling
properties in vivo (35, 37, 38).
Our studies also identify the molecular signaling pathways that
lead to the panoply of defects observed in Ret-null mice, including renal agenesis and complete intestinal aganglionosis as well as
parasympathetic and sympathetic nervous system defects. However,
they also reveal why abnormalities present in the majority of HSCR
patients, such as colon aganglionosis, can occur without involvement of other organs. For example, the phenotype of RET51(Y1062F)
mice is very similar to that reported for HSCR caused by a RET
mutation in the SHC docking site (RET51-M1064T) (40). While the
cellular processes defective in mice expressing RET(Y1062F) remain
to be definitively identified in vivo, the phenotypes are most likely
due to reduced precursor proliferation and migration.
HSCR and CAKUT are complex diseases that can occur singly
or together (7, 40). The abnormalities in these disorders are often
complicated by incomplete penetrance and variable expressivity,
thus making it difficult to delineate the underlying pathogenetic
mechanisms. RET mutations account for the majority of familial
and sporadic HSCR and are also found in many cases of renal aplasia (4, 41). Our comparative analyses of the PNS and genitourinary
system development (29) in these RET isoform/docking tyrosine
mice mutants (Table 2) exhibit remarkable similarities to manifestations of HSCR and CAKUT in humans and provide mechanistic
insights into how RET-mediated signaling defects may lead to various manifestations of these diseases. For example, we discovered
genetic combinations characterized by similarities to HSCR alone
(RET51[Y1062F]), CAKUT alone (RET51[Y1015F]), or to a combination of HSCR and CAKUT (RET9[Y981F] and RET9[Y1062F]). Furthermore, these mutants (e.g., RET51[Y1062F] and RET9[Y981F])
exhibit ENS innervation deficits of varying degrees, a prominent
feature of HSCR, which suggests that aberrant signaling through
these docking sites underlies the variability in HSCR phenotypes.
Notably, mutations within the RET cytoplasmic domain have been
identified in patients with HSCR as well as renal agenesis, although
to our knowledge not in the key docking tyrosines, as they may be
detrimental to life. These include mutations within the cytoplasmic domain (S767R, Y791F, K907E, E921X/K, M980T, M1064T) that
affect residues important for kinase activity or autophosphorylation of the key docking tyrosines (Y981, Y1015, Y1062, and Y1096)
and that can modulate activation of downstream signaling pathways (4, 7, 40, 42–46). Since these docking tyrosines are the major
effectors of GFL-mediated RET activation, these mutant mice pro788

vide in vivo information regarding the signaling pathways whose
disruption influences the likelihood and severity of disease in
patients with CAKUT and HSCR. Importantly, these studies also
suggest that the relative expression of the 2 RET isoforms could
play a key role in the severity of these diseases, as signaling through
Grb2 docking site at Y1096 acts in a synergistic manner with the
other RET signaling pathways.
Several important observations from our study provide insights
into the basis for organotypic specificity in CAKUT and HSCR and
the regulation of PNS and GU development. For example, RETstimulated Plcγ signaling (through Y1015) appears to have different roles in GU versus PNS development. In the GU system, RETPlcγ abrogation results in CAKUT encompassing bilateral defects
including gonadal dysgenesis, ectopic ureters, distal obstruction,
and renal branching abnormalities secondary to enhanced Ret signaling, likely due to inhibition of RTK repressors such as Spry1
(29, 47). However, in enteric and parasympathetic ganglia, cells in
which Spry1 and Ret do not interact (47, 48), reduced Ret signaling results in reduced ganglia formation. It should be noted that
among the cranial parasympathetic ganglia, we limited our analyses to the SPG in this study due to complete penetrance of the SPG
phenotype in Ret-null mice and the relative ease of its analysis and
analysis of its target, the harderian gland, and thus our results are
only relevant to the SPG. Overall in the PNS, tyrosine mutations
in the RET docking site appear to reduce the number of neurons
and axonal projections. This is consistent with studies of HSCR in
which variable aganglionosis is observed regardless of the location
of the mutation (41). However, in the GU system, these key docking
sites appear to have distinct roles: Plcγ in ensuring only a single kidney is formed and PI3K/MAPK in promoting initiation of kidney
formation. We also observed that mice expressing RET9 mutations
that exhibit incomplete penetrance but affect more than one organ
system (i.e., RET9[Y981], RET9[Y1015F]) do not always manifest all
the defects, indicating that individual organs have differential susceptibility or thresholds to the same mutation. For example, defects
in RET(Y981F) animals include CAKUT with a normal ENS, HSCR
with normal kidneys, or CAKUT and HSCR together, detected even
in siblings from the same litter. The basis for these organ-type variations is not entirely clear and is most likely due to tissue-specific
modifier genes or epigenetic mechanisms.
Mice evaluated in this work have a wide range of defects in the
ENS, ANS, and kidneys that mimic human diseases. Although
certain RET-mediated signaling pathways appear more important
for some tissues than others, most of the RET9 mutations affect
at least the ENS, kidney, and parasympathetic nervous systems.
This suggests that more thorough evaluations of these systems in
children with HSCR or CAKUT might be useful. In fact, a recent
study demonstrated that CAKUT anomalies occur in about 25% of
children with HSCR (7). Furthermore, RET mutations have previously been detected in patients presenting with MEN2A in combination with either HSCR or CAKUT (4–7). In particular, tests
for parasympathetic nervous system function (e.g., dry eye disease)
in individuals with HSCR could be helpful. Finally, our discovery
that mice expressing RET(Y1015F), which is the docking site for
Plcγ, have CAKUT along with distal hypoganglionosis suggests
the possibility of subclinical gastrointestinal dysfunction in these
patients that may not present as HSCR.
Specificity and redundancy of individual isoforms of a number
of other RTKs (e.g., Met, PDGFR, insulin receptor, FGFR1) have
an impact on their biological activities (49, 50). We report here
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a comprehensive analysis of key signaling pathways activated by
GFL-mediated RET activation that identified distinct as well as
redundant roles for ENS, ANS, and kidney development.
Methods
Generation of various RET knockin mice. All animal studies were approved by
the Washington University Animal Studies Committee. Human RET9,
RET51, and the indicated mutant cDNAs were homologously recombined
into the first coding exon of the Ret gene to disrupt synthesis of the endogenous mouse Ret as previously described (Figure 1 and Table 1) (29). All
experiments were performed on homozygous mice with a mixed genetic
background (129/SvJ:C57BL/6) obtained by breeding of corresponding
hemizygous parents.
Histopathological and morphological analysis of the PNS. Mouse tissues were
harvested at the indicated ages, fixed in 4% paraformaldehyde, and processed as previously described (11). Routine histological assessment was
done on H&E-stained tissue sections.
Evaluation of the ENS was done using whole-mount AChE staining on
dissected gastrointestinal tract of newborn (P0) or postnatal mice. The extent
of aganglionosis was determined as a percentage of large or small bowel that
was not colonized by enteric neurons as previously described (11, 51, 52).
Catecholaminergic sympathetic neurons were visualized with diaminobenzidine by means of whole-mount TH immunohistochemistry (rabbit
polyclonal antibody, 1:200; Chemicon) on paraformaldehyde-fixed P0
mouse pups as described (10).
The location and number of SPG neurons was determined from thioninstained (Nissl), paraffin-embedded coronal head sections (6 μm) of newborn mice. Since slight variations in embedding/sectioning angle could
influence simultaneous appearance of this small ganglion from both sides
in the same section, the region encompassing the entire ganglion was
sectioned, and neurons with distinct nucleoli were counted at 120-μm
intervals (at least 3 animals, 6 ganglia, from each genotype) as previously
described (11). The histological and anatomical annotation and plane of
sections are depicted in Figure 2, E–H.
The innervation of intraorbital harderian gland was examined on cryosections (10 μm) of fixed tissue with rabbit class III β-tubulin antibody
(1:500; Covance) and visualized with Cy3-conjugated anti-rabbit secondary antibody (1:200; Jackson Immunoresearch Laboratories). Differences
in innervation were determined by measuring area covered by Cy3-positive
profiles (pixel2) in 5 independent fields (×20) from each genotype (n = 3)
using Metamorph Premier software (Molecular Devices).
Enteric neuron studies in vitro. Enteric neural crest precursors were harvested
from E14.5 Sprague Dawley rat (Charles River Laboratories) intestines
using p75NTR antibody (53). Briefly, single-cell suspension was obtained
after collagenase (1 mg/ml) and dispase (1 mg/ml) dissociation, followed
by p75NTR antibody incubation (1:1000, 1 hour, 4°C; gift from Moses
Chao, New York University, New York, NY, USA) in B27-supplemented
(Invitrogen) Neurobasal medium, and goat anti-rabbit coupled paramag1. Madhani HD. Accounting for specificity in receptor
tyrosine kinase signaling. Cell. 2001;106(1):9–11.
2. Ponder BA, Smith D. The MEN II syndromes and
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